This case is the first in a three-part series that explores the multifaceted organizational and strategic decisions that companies are facing as a result of the global AIDS epidemic. Heineken considers to be one of the first companies to offer AIDS drugs (antiretroviral therapy) for employees and their families. Hans Wesseling, corporate HR manager, and his colleagues from the Faculty of Medicine to review the institutional, financial and social consequences of this decision and to make recommendations to the Council. Shows how Heineken in fighting the epidemic and considering it as part of its corporate social responsibility. "Hide
by Diane Barrett, Daniella Ballou Source: Harvard Business School 14 pages. Publication Date: January 27, 2003. Prod. #: 303063-PDF-ENG
Related Case Solutions & Analyses:
Cisco Acquires Linksys
The Three Strikes Law in California: The Ballot Initiative
The Book Deal: Confidential Instructions for the AGENT
Monroe Clock Company (B)
Whirlpools Roadmap in China: 2004
Introduction to Patents and Trade Secrets
Lyric Dinner Theatre: Deborah Denenberg General Manager Video
FERKNOT
Xiameter
Genrays – Implementing The New Hris System
